TIPE2 acts as a biomarker for GIST risk category and suppresses the viability and invasiveness of GIST cells
Evaluating the risk category of gastrointestinal stromal tumors (GISTs) is crucial for predicting prognosis and choosing treatment strategies, and tumor metastasis usually represent poor prognosis. Tumor necro...
Citation: Cell & Bioscience 2018 8:62